Study of Efficacy and Safety of Secukinumab in Psoriatic Arthritis and Axial Spondyloarthritis Patients With Active Enthesitis Including One Achilles Tendon Site

NCT02771210 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

204

Enrollment

INDUSTRY

Sponsor class

Conditions

Psoriatic Arthritis
Axial Spondyloarthritis
Enthesitis

Interventions

BIOLOGICAL: Secukinumab
DRUG: Secukinumab Placebo

Sponsor

Novartis Pharmaceuticals